Susquehanna International Group, LLP Novavax Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $823,599 - $1.32 Million	76,900 Added 3.42%	2,326,300 $29.4 Million
Q2 2024 Aug 15, 2024	BUY	$3.89 - $20.97 $2.01 Million - $10.9 Million	517,600 Added 29.89%	2,249,400 $28.5 Million
Q1 2024 May 07, 2024	BUY	$3.76 - $6.02 $55,272 - $88,494	14,700 Added 0.86%	1,731,800 $8.28 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $3.3 Million - $5.27 Million	-686,600 Reduced 28.56%	1,717,100 $8.24 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $2.35 Million - $3.36 Million	345,100 Added 16.76%	2,403,700 $17.4 Million
Q2 2023 Aug 11, 2023	SELL	$6.67 - $9.52 $6.06 Million - $8.65 Million	-908,700 Reduced 30.62%	2,058,600 $15.3 Million
Q1 2023 May 16, 2023	BUY	$5.76 - $12.48 $5.89 Million - $12.8 Million	1,022,100 Added 52.54%	2,967,300 $20.6 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $6.55 Million - $18.5 Million	739,700 Added 61.36%	1,945,200 $20 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $1.84 Million - $7.69 Million	-101,000 Reduced 7.73%	1,205,500 $21.9 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $13.8 Million - $28.5 Million	379,000 Added 40.86%	1,306,500 $67.2 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $72.1 Million - $148 Million	-1,034,400 Reduced 52.72%	927,500 $68.3 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $119 Million - $192 Million	881,500 Added 81.59%	1,961,900 $281 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $47.5 Million - $72.2 Million	-266,900 Reduced 19.81%	1,080,400 $224 Million
Q2 2021 Aug 11, 2021	SELL	$121.0 - $257.67 $34.3 Million - $73 Million	-283,400 Reduced 17.38%	1,347,300 $286 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $15.9 Million - $45 Million	140,700 Added 9.44%	1,630,700 $296 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $17.1 Million - $30.3 Million	217,500 Added 17.09%	1,490,000 $166 Million
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $4.83 Million - $10.9 Million	60,800 Added 5.02%	1,272,500 $138 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $7.88 Million - $47.5 Million	568,700 Added 88.44%	1,211,700 $101 Million
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $1.69 Million - $6.89 Million	-430,400 Reduced 40.1%	643,000 $8.73 Million
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $812,538 - $1.15 Million	220,200 Added 25.81%	1,073,400 $4.27 Million
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.84 $1.29 Million - $2.51 Million	-320,600 Reduced 27.31%	853,200 $4.28 Million
Q2 2019 Nov 14, 2019	BUY	$4.93 - $12.2 $5.79 Million - $14.3 Million	1,173,800 New	1,173,800 $6.88 Million

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account